
Association of VA Surgeons - Home
The Association of VA Surgeons was established in 1967 to improve patient care, medical education and research within the Department of Veterans Affairs. We are an independent, non-profit …
Single-port thoracoscopic removal of an azygos vein aneurysm: a case ...
Jan 16, 2023 · Thoracoscopic surgery to remove AVAs is difficult and has a high risk of bleeding, while more minimally invasive single-port thoracoscopic surgery is also safe and effective for the treatment …
Robotic Resection of an Idiopathic Azygos Vein Aneurysm and the ...
May 16, 2025 · To date, 73 cases of idiopathic AVAs have been reported worldwide, 4 with the largest case series comprising 10 patients. 1 With so few reported cases, no standard diagnostic or …
Surgical Resection of a Giant Azygos Vein Aneurysm
In this report, we present the case of a large thrombosed AVA and its successful treatment. We propose surgical resection as a safe and effective management strategy for similar giant thrombosed AVAs.
Association of VA Surgeons - Meetings
The Annual AVAS Meeting: Offers an annual conference to present and advance scientific knowledge to members with the goal of improving the quality of care provided for Veterans
Association of VA Surgeons - 2026 Meeting
We will be at the Hyatt Regency Newport Beach in Newport Beach, CA on April 26 - 28, 2025. More information will be available in the coming months. Please share with your colleagues and friends! …
Association of VA Surgeons - 2025 Meeting
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Association of VA Surgeons (AVAS).
Association of VA Surgeons - Future Meetings
Association of VA Surgeons.
Association of VA Surgeons - Manuscript
Jul 31, 2025 · Authors of abstracts accepted for the meeting are invited to submit a manuscript to JAMA Surgery, the official publication of the Association of VA Surgeons. Manuscript submission is optional …
The AVAS® | AllVascular
This page describes how the AVAS® works. The AVAS® enables the isolated and targeted delivery of chemotherapy to cancerous organs.